^
BIOMARKER:

FLT3-ITD mutation

i
Other names: FLT3, Fms Related Tyrosine Kinase 3, Receptor-Type Tyrosine-Protein Kinase FLT3, Stem Cell Tyrosine Kinase 1, Fms-Like Tyrosine Kinase 3, CD135, FLK-2, STK1, Growth Factor Receptor Tyrosine Kinase Type III, Fetal Liver Kinase 2




Show legend

Include preclinical:
Acute Myelogenous Leukemia
midostaurin
venetoclax + azacitidine
midostaurin + gemtuzumab ozogamicin
decitabine
venetoclax
ponatinib
TP-0903
PHI-101
pexidartinib
quizartinib + RAIN-32
venetoclax + quizartinib
HEC73543
ARO-002
gilteritinib + quizartinib
quizartinib
gilteritinib
venetoclax + gilteritinib
gemtuzumab ozogamicin
sorafenib
sorafenib + gilteritinib
venetoclax + ruxolitinib
FF-10101
gilteritinib + PIN-A1
cytarabine
selumetinib
gilteritinib + PRT811
gilteritinib + DUP 785
PLD-102
midostaurin + 20D9-ADC
gilteritinib + SHP099
PIN-A1
SGN-CD33A
bortezomib + verteporfin
bortezomib
Max-40279
ABBV-744
venetoclax + SM09419
venetoclax + IACS-010759
midostaurin + SM09419
dasatinib
CPI-0610
olverembatinib + APG-115
sorafenib + GMI-1359
sorafenib
venetoclax + midostaurin
LAM 003
ARO-002 + Wu-5
gilteritinib + CUDC-907
venetoclax + AMG 176
quizartinib + PLX51107
PLX51107
SM09419
quizartinib + LY2510924
venetoclax + LAM 003
palbociclib
SB939 + pacritinib
olaparib
venetoclax + ONO-7475
quizartinib + Lys05
quizartinib + IMGN779
AIU2008
DT-061
olverembatinib + APG-2575
gilteritinib + AMG 176
quizartinib + STF-083010
STF-083010
quizartinib + PF-04691502
TKI258
quizartinib + AZD1208
quizartinib + GMI-1359
gilteritinib + AZD1208
pelareorep
quizartinib + CC-90009
ponatinib + SB-715992
cabozantinib tablet
cabozantinib tablet + SB-715992
CDDD11-8
EC-70124
TP-0184
P22077
venetoclax
DCAG
DA
FLT3 inhibitor + LIMK2 inhibitor
Bcl2 inhibitor + Tyrosine kinase inhibitor
FLT3 inhibitor + BET inhibitor
FLT3 inhibitor